Get started
Author

Michel Vierboom

Observed names: M P M Vierboom, M P Vierboom, M Vierboom, M. P. M. Vierboom, M. Vierboom, MICHEL P. M. VIERBOOM, Michel P M Vierboom, Michel P. M. Vierboom, Michel P. Vierboom, Michel P.M. Vierboom, Michel PM Vierboom
Observed institutions: Leiden University, Netherlands Organisation for Applied Scientific Research, University of Antwerp, Loyola University Chicago, Leiden University Medical Center, Biomedical Primate Research Centre, Amsterdam UMC Location University of Amsterdam
ORCID: 0000-0002-1865-7532
Observed ORCID: 0000-0002-1865-7532
OpenAlex ID: A5069049117
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
1993 · Mariet C. W. Feltkamp, Henk L. Smits, et al. · European Journal of Immunology · 823
Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques
2019 · Karin Dijkman, Claudia C. Sombroek, et al. · Nature Medicine · 283
Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
1997 · Michel P.M. Vierboom, Hans W. Nijman, et al. · The Journal of Experimental Medicine · 206
Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes
1993 · Hans W. Nijman, Jos G. A. Houbiers, et al. · European Journal of Immunology · 191
PDF
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
2015 · Maarten Van Roy, Cedric Ververken, et al. · Arthritis Research & Therapy · 190
PDF
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
1995 · H W Nijman, M J Kleijmeer, et al. · The Journal of Experimental Medicine · 178
PDF
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
2001 · Bart J.M. van Vlijmen, Gery Gerritsen, et al. · Circulation Research · 175
Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumors
1995 · Mariet C. W. Feltkamp, Gienke R. Vreugdenhil, et al. · European Journal of Immunology · 163
PDF
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
1998 · M L De Bruijn, D H Schuurhuis, et al. · PubMed · 137
Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination
2021 · Michel P.M. Vierboom, Karin Dijkman, et al. · Cell Reports Medicine · 96
PDF
Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity
1994 · Mariet C.W. Feltkamp, Michel P.M. Vierboom, et al. · Molecular Immunology · 95
Inhibition of the development of collagen‐induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5
2005 · Michel P. M. Vierboom, Paul J. Zavodny, et al. · Arthritis & Rheumatism · 94
Preclinical models of arthritic disease in non-human primates
2007 · Michel P.M. Vierboom, Margreet Jonker, et al. · Drug Discovery Today · 64
Modeling human arthritic diseases in nonhuman primates.
2005 · Michel PM Vierboom, Margreet Jonker, et al. · Arthritis Research & Therapy · 62
PDF
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells.
2002 · Sander Zwaveling, Michel P M Vierboom, et al. · PubMed · 60
High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.
2000 · M P Vierboom, S Zwaveling, et al. · PubMed · 60
p53: A Potential Target Antigen for Immunotherapy of Cancer
2000 · RIENK OFFRINGA, MICHEL P. M. VIERBOOM, et al. · Annals of the New York Academy of Sciences · 56
Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice
2014 · Ingrid Lindh, Omri Snir, et al. · Arthritis Research & Therapy · 55
PDF
Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
2021 · Karin Dijkman, Nacho Aguilo, et al. · Cell Reports Medicine · 52
PDF
Characterization of Cytotoxic T Lymphocyte Epitopes of a Self-Protein, p53, and a Non-Self-Protein, Influenza Matrix: Relationship Between Major Histocompatibility Complex Peptide Binding Affinity and Immune Responsiveness to Peptides
1993 · Hans W. Nijman, Jos G. A. Houbiers, et al. · Journal of Immunotherapy · 51
PDF
Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL
2000 · Michel P.M. Vierboom, Gerard M.J. Bos, et al. · International Journal of Cancer · 46
Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity
2019 · Karin Dijkman, Richard A. W. Vervenne, et al. · Frontiers in Immunology · 45
PDF
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus)
2013 · S. Anwar Jagessar, Michel Vierboom, et al. · EXPERIMENTAL ANIMALS · 39
PDF
Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis
2010 · Michel PM Vierboom, Elia Breedveld, et al. · Arthritis Research & Therapy · 36
PDF
Peptide Vaccination with an Anchor-Replaced CTL Epitope Protects Against Human Papillomavirus Type 16-Induced Tumors Expressing the Wild-Type Epitope
1998 · Michel P. M. Vierboom, Mariet C. W. Feltkamp, et al. · Journal of Immunotherapy · 35
Works count: 58
Citation count: 3,685
H-index: 30
I10-index: 39
Year
Topic
Type